The imbalance of T helper 17/regulatory T cells and memory B cells during the early post-transplantation period in peripheral blood of living donor liver transplantation recipients under calcineurin inhibitor-based immunosuppression

Immunology

Volumn 138, Issue 2, 2013, Pages 124-133

  Kim, Hee Yeon ^a   Cho, Mi La ^a   Jhun, Joo Yeon ^a   Byun, Jae Kyeong ^a   Kim, Eun Kyung ^a   Yim, Ye Been ^a   Chung, Byung Ha ^a   Yoon, Seung Kew ^a   Bae, Si Hyun ^a   Kim, Dong Goo ^a   Yang, Chul Woo ^a   Choi, Jong Young ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Calcineurin inhihitor; Early post transplantaion period; Human; Liver transplantation; Regulatory T cell; T helper type 17 cells

Indexed keywords

CALCINEURIN INHIBITOR; CD19 ANTIGEN; CD24 ANTIGEN; CD38 ANTIGEN; CORTICOSTEROID; CYCLOSPORIN A; INTERLEUKIN 17; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ARTICLE; BLOOD; CLINICAL ARTICLE; CLINICAL PRACTICE; CYTOKINE PRODUCTION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTER; GRAFT RECIPIENT; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; MEMORY CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL;

ADULT; B-LYMPHOCYTES; CALCINEURIN; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; T-LYMPHOCYTES, REGULATORY; TACROLIMUS; TH1 CELLS; TH17 CELLS; TH2 CELLS;

EID: 84872580584     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12021     Document Type: Article

References (30)

1. Castellaneta A, Thomson AW, Nayyar N, de Vera M, Mazariegos GV. Monitoring the operationally tolerant liver allograft recipient. Curr Opin Organ Transplant 2010; 15:28-34.
2. Grinyó JM, Cruzado JM. Mycophenolate mofetil and calcineurin-inhibitor reduction: recent progress. Am J Transplant 2009; 9:2447-52.
3. Lechler RI, Sykes M, Thomson AW, Turka LA. Organ transplantation - how much of the promise has been realized? Nat Med 2005; 11:605-13.
4. Taylor AL, Watson CJ, Bradley JA. Immunosuppressive agents in solid organ transplantation: mechanisms of action and therapeutic efficacy. Crit Rev Oncol Hematol 2005; 56:23-46.
5. Sayegh MH, Carpenter CB. Transplantation 50 years later - progress, challenges, and promises. N Engl J Med 2004; 351:2761-6.
6. Eksteen B, Neuberger JM. Mechanisms of disease: the evolving understanding of liver allograft rejection. Nat Clin Pract Gastroenterol Hepatol 2008; 5:209-19.
7. Gras J, Wieërs G, Vaerman JL et al. Early immunological monitoring after pediatric liver transplantation: cytokine immune deviation and graft acceptance in 40 recipients. Liver Transpl 2007; 13:426-33.
8. Wang YL, Tang ZQ, Gao W, Jiang Y, Zhang XH, Peng L. Influence of Th1, Th2, and Th3 cytokines during the early phase after liver transplantation. Transplant Proc 2003; 35:3024-5.
9. Ganschow R, Broering DC, Nolkemper D, Albani J, Kemper MJ, Rogiers X, Burdelski M. Th2 cytokine profile in infants predisposes to improved graft acceptance after liver transplantation. Transplantation 2001; 72:929-34.
10. Asakura T, Ohkohchi N, Satomi S. Changes of serum cytokines associated with hepatic regeneration after living-related liver transplantation. Transplant Proc 2000; 32:2199-203.
11. Minguela A, Torío A, Marín L, Sanchez-Bueno F, Garcia-Alonso AM, Ontanon J, Parrilla P, Alvarez-Lopez MR. Implication of Th1, Th2, and Th3 cytokines in liver graft acceptance. Transplant Proc 1999; 31:519-20.
12. Zhao L, Qiu de K, Ma X. Th17 cells: the emerging reciprocal partner of regulatory T cells in the liver. J Dig Dis 2010; 11:126-33.
13. Rong G, Zhou Y, Xiong Y et al. Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population. Clin Exp Immunol 2009; 156:217-25.
14. Awasthi A, Murugaiyan G, Kuchroo VK. Interplay between effector Th17 and regulatory T cells. J Clin Immunol 2008; 28:660-70.
15. Mitsdoerffer M, Lee Y, Jäger A et al. Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc Natl Acad Sci U S A 2010; 107:14292-7.
16. Starzl TE, Murase N, Thomson AW, Trucco M, Rao A. Immunity and tolerance are related, and governed by antigen migration and localization. Transplant Proc 1999; 31:1406-11.
17. Taner T, Gandhi MJ, Sanderson SO, Poterucha CR, De Goey SR, Stegall MD, Heimbach JK. Prevalence, course and impact of HLA donor-specific antibodies in liver transplantation in the first year. Am J Transplant 2012; 12:1504-10.
18. Sakamoto R, Asonuma K, Zeledon Ramirez ME, Yoshimoto K, Nishimori A, Inomata Y. Forkhead box P3 (FOXP3) mRNA expression immediately after living-donor liver transplant. Exp Clin Transplant 2009; 7:8-12.
19. + T cells in peripheral blood after liver transplantation: association with immunosuppression. Transplant Proc 2005; 37:1194-6.
20. Hammerich L, Heymann F, Tacke F. Role of IL-17 and Th17 cells in liver diseases. Clin Dev Immunol 2011; 2011: 345803.
21. Heidt S, San D, Chadha R, Wood KJ. The impact of Th17 cells on transplant rejection and the induction of tolerance. Curr Opin Organ Transplant 2010; 15:456.
22. Burrell BE, Bishop DK. Th17 cells and transplant acceptance. Transplantation 2010; 90:945-8.
23. Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med 2004; 351:2715-29.
24. Abadja F, Videcoq C, Alamartine E, Berthoux F, Mariat C. Differential effect of cyclosporine and mycophenolic acid on the human regulatory T cells and TH-17 cells balance. Transplant Proc 2009; 41:3367-70.
25. Haider AS, Lowes MA, Suárez-Fariñas M et al. Identification of cellular pathways of "type 1", Th17 T cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A in psoriasis. J Immunol 2008; 180:1913-20.
26. Liu Z, Yuan X, Luo Y, He Y, Jiang Y, Chen ZK, Sun E. Evaluating the effects of immunosuppressants on human immunity using cytokine profiles of whole blood. Cytokine 2009; 45:141-7.
27. Zhang C, Zhang J, Yang B, Wu C. Cyclosporin A inhibits the production of IL-17 by memory Th17 cells from healthy individuals and patients with rheumatoid arthritis. Cytokine 2008; 42:345-52.
28. Ziolkowska M, Koc A, Luszczykiewicz G, Ksiezopolska-Pietrzak K, Klimczak E, Chwalinska-Sadowska H, Maslinski W. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol 2000; 164:2832-8.
29. + T cells via down-regulation of PI3K/Akt and NF-κB. Immunol Lett 2007; 108:88-96.
30. Jones ND. Memory T cells: how might they disrupt the induction of tolerance? Transplantation 2009; 87:S74-7.